Trial
NCT02730962
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
—
Condition
Pre-Diabetes
Intervention
Vancomycin
Why stopped
Delays in IND approval caused a lack of funding to conduct the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-22